-
A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
Richard T. Kloos, Robert J. Monroe, S. Thomas Traweek, Richard B. Lanman, and Giulia C. Kennedy
Thyroid
(2016)
26 :785
-
Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience
Shuanzeng Wei, Virginia A. LiVolsi, Kathleen T. Montone, Jennifer J. D. Morrissette, and Zubair W. Baloch
Endocrine Pathology
(2016)
27 :359
-
Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells
Alessandro Antonelli and Concettina La Motta
Medicinal Research Reviews
(2017)
37 :1299
-
Heterogeneity of Thyroid Cancer
Ewa Chmielik, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Michal Jarzab, Jolanta Krajewska, Agnieszka Czarniecka, and
Barbara Jarzab
Pathobiology
(2018)
85 :117
-
The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
Marina De Rosa, Daniela Rega, Valeria Costabile, Francesca Duraturo, Antonello Niglio, Paola Izzo, Ugo Pace, and Paolo Delrio
Therapeutic Advances in Gastroenterology
(2016)
9 :861
-
Advances and controversies in the management of medullary thyroid carcinoma
Ana Luiza Maia, Simone Magagnin Wajner, and Carla Vaz Ferreira Vargas
Current Opinion in Oncology
(2017)
29 :25
-
New drugs for medullary thyroid cancer: new promises?
Christine Spitzweg, John C Morris, and Keith C Bible
Endocrine-Related Cancer
(2016)
23 :R287
-
Role of bioactive lipofishins in prevention of inflammation and colon cancer
Valter R.M. Lombardi, Iván Carrera, Lola Corzo, and Ramón Cacabelos
Seminars in Cancer Biology
(2017)
:
-
Animal models of medullary thyroid cancer: state of the art and view to the future
Giovanni Vitale, Germano Gaudenzi, Luisa Circelli, Marco F Manzoni, Andrea Bassi, Niccolò Fioritti, Antongiulio Faggiano,
and Annamaria Colao
Endocrine-Related Cancer
(2017)
24 :R1
-
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with doubleRETmutations
Cristina Romei, Francesca Casella, Alessia Tacito, Valeria Bottici, Laura Valerio, David Viola, Virginia Cappagli, Antonio
Matrone, Raffaele Ciampi, Paolo Piaggi, Clara Ugolini, Liborio Torregrossa, Fulvio Basolo, Gabriele Materazzi, Paolo Vitti,
and Rossella Elisei
Journal of Medical Genetics
(2016)
53 :729
-
Lenvatinib: Role in thyroid cancer and other solid tumors
Maria E. Cabanillas and Mouhammed Amir Habra
Cancer Treatment Reviews
(2016)
42 :47
-
Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression
Ying-Hsia Chu and Ricardo V. Lloyd
Endocrine Pathology
(2016)
27 :312
-
Refractory thyroid carcinoma: which systemic treatment to use?
Laurence Faugeras, Anne-Sophie Pirson, Julian Donckier, Luc Michel, Julien Lemaire, Sebastien Vandervorst, and Lionel D’Hondt
Therapeutic Advances in Medical Oncology
(2018)
10 :175883401775285
-
Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors
Samuel A Wells
Endocrine-Related Cancer
(2018)
25 :T1
-
Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic
Disease
S. Jayakody, J. Reagh, M. Bullock, A. Aniss, R. Clifton-Bligh, D. Learoyd, B. Robinson, L. Delbridge, S. Sidhu, A. J. Gill,
and M. Sywak
World Journal of Surgery
(2018)
42 :1432
-
Recent advances in the biology and therapy of medullary thyroid carcinoma
Barry Nelkin
F1000Research
(2017)
6 :2184
-
DNA microarray-based resonance light scattering assay for multiplexed detection of DNA mutation in papillary thyroid cancer
Yaoqi Wang, Jiaxue Gao, Xianying Meng, and Zhenxin Wang
The Analyst
(2018)
143 :914
-
NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May
Have a Role in Triaging Genetic Testing for MEN2
Jessica Reagh, Martyn Bullock, Juliana Andrici, John Turchini, Loretta Sioson, Adele Clarkson, Nicole Watson, Amy Sheen, Grace
Lim, Leigh Delbridge, Stan Sidhu, Mark Sywak, Ahmad Aniss, Phillip Shepherd, Daniel Ng, Paul Oei, Michael Field, Diana Learoyd,
Bruce G. Robinson, Roderick J. Clifton-Bligh, and Anthony J. Gill
The American Journal of Surgical Pathology
(2017)
41 :75
-
Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma
Daniel G. Pankratz, Zhanzhi Hu, Su Yeon Kim, Robert J. Monroe, Mei G. Wong, S. Thomas Traweek, Richard T. Kloos, P. Sean Walsh,
and Giulia C. Kennedy
Thyroid
(2016)
26 :1573
-
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
Cristina Romei, Raffaele Ciampi, and Rossella Elisei
Nature Reviews Endocrinology
(2016)
12 :192
-
Whole exome sequencing identifies a germline MET
mutation in two siblings with hereditary wild-type RET
medullary thyroid cancer
Marialuisa Sponziello, Silvia Benvenuti, Alessandra Gentile, Valeria Pecce, Francesca Rosignolo, Anna Rita Virzì, Melissa
Milan, Paolo M. Comoglio, Eric Londin, Paolo Fortina, Agnese Barnabei, Marialuisa Appetecchia, Ferdinando Marandino, Diego
Russo, Sebastiano Filetti, Cosimo Durante, and Antonella Verrienti
Human Mutation
(2018)
39 :371
-
Signaling pathways in medullary thyroid carcinoma: therapeutic implications
Zahra Nozhat, Mehdi Hedayati, and Hoda Pourhassan
International Journal of Endocrine Oncology
(2016)
3 :299
-
Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases
Sadegh Rajabi and Mehdi Hedayati
Molecular Diagnosis & Therapy
(2017)
21 :607
-
Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma
Elizabeth G. Grubbs, Michelle D. Williams, Paul Scheet, Selina Vattathil, Nancy D. Perrier, Jeffrey E. Lee, Robert F. Gagel,
Tao Hai, Lei Feng, Maria E. Cabanillas, and Gilbert J. Cote
Thyroid
(2016)
26 :1553
-
Biologic and Clinical Perspectives on Thyroid Cancer
Dan L. Longo, James A. Fagin, and Samuel A. Wells
New England Journal of Medicine
(2016)
375 :1054
-
Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish
Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)
E. Grande, J. Santamaría Sandi, J. Capdevila, E. Navarro González, C. Zafón Llopis, T. Ramón y Cajal Asensio, J. M. Gómez
Sáez, P. Jiménez-Fonseca, G. Riesco-Eizaguirre, and J. C. Galofré
Clinical and Translational Oncology
(2016)
18 :769
